Literature DB >> 21779761

Mechanisms for Kir channel inhibition by quinacrine: acute pore block of Kir2.x channels and interference in PIP2 interaction with Kir2.x and Kir6.2 channels.

Angélica López-Izquierdo1, Iván A Aréchiga-Figueroa, Eloy G Moreno-Galindo, Daniela Ponce-Balbuena, Martín Rodríguez-Martínez, Tania Ferrer-Villada, Aldo A Rodríguez-Menchaca, Marcel A G van der Heyden, José A Sánchez-Chapula.   

Abstract

Cardiac inward rectifier potassium currents determine the resting membrane potential and contribute repolarization capacity during phase 3 repolarization. Quinacrine is a cationic amphiphilic drug. In this work, the effects of quinacrine were studied on cardiac Kir channels expressed in HEK 293 cells and on the inward rectifier potassium currents, I(K1) and I(KATP), in cardiac myocytes. We found that quinacrine differentially inhibited Kir channels, Kir6.2Kir2.3 > Kir2.1. In addition, we found in cardiac myocytes that quinacrine inhibited I(KATP) > I(K1). We presented evidence that quinacrine displays a double action towards strong inward rectifier Kir2.x channels, i.e., direct pore block and interference in phosphatidylinositol 4,5-bisphosphate, PIP(2)-Kir channel interaction. Pore block is evident in Kir2.1 and 2.3 channels as rapid block; channel block involves residues E224 and E299 facing the cytoplasmic pore of Kir2.1. The interference of the drug with the interaction of Kir2.x and Kir6.2/SUR2A channels and PIP(2) is suggested from four sources of evidence: (1) Slow onset of current block when quinacrine is applied from either the inside or the outside of the channel. (2) Mutation of Kir2.3(I213L) and mutation of Kir6.2(C166S) increase their affinity for PIP(2) and lowers its sensitivity for quinacrine. (3) Mutations of Kir2.1(L222I and K182Q) which decreased its affinity for PIP(2) increased its sensitivity for quinacrine. (4) Co-application of quinacrine with PIP(2) lowers quinacrine-mediated current inhibition. In conclusion, our data demonstrate how an old drug provides insight into a dual a blocking mechanism of Kir carried inward rectifier channels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21779761     DOI: 10.1007/s00424-011-0995-5

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  45 in total

1.  Localization of PIP2 activation gate in inward rectifier K+ channels.

Authors:  Jun Xiao; Xiao-guang Zhen; Jian Yang
Journal:  Nat Neurosci       Date:  2003-08       Impact factor: 24.884

2.  Selective inhibition of Kir currents by antihistamines.

Authors:  Boyi Liu; Zhanfeng Jia; Xian Geng; Junjie Bei; Zhiying Zhao; Qingzhong Jia; Hailin Zhang
Journal:  Eur J Pharmacol       Date:  2006-12-01       Impact factor: 4.432

3.  Do anionic phospholipids serve as cofactors or second messengers for the regulation of activity of cloned ATP-sensitive K+ channels?

Authors:  Kathryn V Quinn; Yi Cui; Jonathan P Giblin; Lucie H Clapp; Andrew Tinker
Journal:  Circ Res       Date:  2003-09-11       Impact factor: 17.367

4.  Cytoplasmic domain structures of Kir2.1 and Kir3.1 show sites for modulating gating and rectification.

Authors:  Scott Pegan; Christine Arrabit; Wei Zhou; Witek Kwiatkowski; Anthony Collins; Paul A Slesinger; Senyon Choe
Journal:  Nat Neurosci       Date:  2005-02-20       Impact factor: 24.884

Review 5.  Lipidosis induced by amphiphilic cationic drugs.

Authors:  H Lüllmann; R Lüllmann-Rauch; O Wassermann
Journal:  Biochem Pharmacol       Date:  1978       Impact factor: 5.858

6.  Arrhythmogenic and antiarrhythmic effects of lipolytic factors on cultured heart cells.

Authors:  D G Wenzel; J D Innis
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1983-09

7.  Blockade of currents by the antimalarial drug chloroquine in feline ventricular myocytes.

Authors:  J A Sánchez-Chapula; E Salinas-Stefanon; J Torres-Jácome; D E Benavides-Haro; R A Navarro-Polanco
Journal:  J Pharmacol Exp Ther       Date:  2001-04       Impact factor: 4.030

8.  Genetic disruption of Kir6.2, the pore-forming subunit of ATP-sensitive K+ channel, predisposes to catecholamine-induced ventricular dysrhythmia.

Authors:  Xiao-Ke Liu; Satsuki Yamada; Garvan C Kane; Alexey E Alekseev; Denice M Hodgson; Fearghas O'Cochlain; Arshad Jahangir; Takashi Miki; Susumu Seino; Andre Terzic
Journal:  Diabetes       Date:  2004-12       Impact factor: 9.461

Review 9.  The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination.

Authors:  D J Wallace
Journal:  Semin Arthritis Rheum       Date:  1989-05       Impact factor: 5.532

10.  Intrinsic versus extrinsic voltage sensitivity of blocker interaction with an ion channel pore.

Authors:  Juan Ramón Martínez-François; Zhe Lu
Journal:  J Gen Physiol       Date:  2010-02       Impact factor: 4.086

View more
  9 in total

1.  Inward rectifying potassium currents resolved into components: modeling of complex drug actions.

Authors:  Jiří Šimurda; Milena Šimurdová; Markéta Bébarová
Journal:  Pflugers Arch       Date:  2017-09-26       Impact factor: 3.657

2.  Inhibition of inwardly rectifying Kir2.x channels by the novel anti-cancer agent gambogic acid depends on both pore block and PIP2 interference.

Authors:  Daniel Scherer; Benedikt Schworm; Claudia Seyler; Panagiotis Xynogalos; Eberhard P Scholz; Dierk Thomas; Hugo A Katus; Edgar Zitron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-04-02       Impact factor: 3.000

3.  Class III antiarrhythmic drug dronedarone inhibits cardiac inwardly rectifying Kir2.1 channels through binding at residue E224.

Authors:  Panagiotis Xynogalos; Claudia Seyler; Daniel Scherer; Christoph Koepple; Eberhard P Scholz; Dierk Thomas; Hugo A Katus; Edgar Zitron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-09-04       Impact factor: 3.000

4.  Aminophylline at clinically relevant concentrations affects inward rectifier potassium current in a dual way.

Authors:  Nuno Jorge Dourado Ramalho; Olga Švecová; Roman Kula; Milena Šimurdová; Jiří Šimurda; Markéta Bébarová
Journal:  Pflugers Arch       Date:  2022-01-26       Impact factor: 3.657

5.  Inhibition of Kir4.1 potassium channels by quinacrine.

Authors:  Leticia G Marmolejo-Murillo; Iván A Aréchiga-Figueroa; Meng Cui; Eloy G Moreno-Galindo; Ricardo A Navarro-Polanco; José A Sánchez-Chapula; Tania Ferrer; Aldo A Rodríguez-Menchaca
Journal:  Brain Res       Date:  2017-03-11       Impact factor: 3.252

6.  Molecular mechanisms of chloroquine inhibition of heterologously expressed Kir6.2/SUR2A channels.

Authors:  Daniela Ponce-Balbuena; Aldo A Rodríguez-Menchaca; Angélica López-Izquierdo; Tania Ferrer; Harley T Kurata; Colin G Nichols; José A Sánchez-Chapula
Journal:  Mol Pharmacol       Date:  2012-07-31       Impact factor: 4.436

7.  Discovery, characterization, and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with preference for Kir2.3, Kir3.x, and Kir7.1.

Authors:  Rene Raphemot; Daniel F Lonergan; Thuy T Nguyen; Thomas Utley; L Michelle Lewis; Rishin Kadakia; C David Weaver; Rocco Gogliotti; Corey Hopkins; Craig W Lindsley; Jerod S Denton
Journal:  Front Pharmacol       Date:  2011-11-30       Impact factor: 5.810

8.  Inward rectifier potassium (Kir) current in dopaminergic periglomerular neurons of the mouse olfactory bulb.

Authors:  Mirta Borin; Alex Fogli Iseppe; Angela Pignatelli; Ottorino Belluzzi
Journal:  Front Cell Neurosci       Date:  2014-08-08       Impact factor: 5.505

9.  Development of IKATP Ion Channel Blockers Targeting Sulfonylurea Resistant Mutant KIR6.2 Based Channels for Treating DEND Syndrome.

Authors:  Marien J C Houtman; Theres Friesacher; Xingyu Chen; Eva-Maria Zangerl-Plessl; Marcel A G van der Heyden; Anna Stary-Weinzinger
Journal:  Front Pharmacol       Date:  2022-01-14       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.